Navigation Links
Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension
Date:5/15/2008

APPENZELL, Switzerland, May 15 /PRNewswire/ -- Ergonex Pharma today announced that the United States Food and Drug Administration (FDA) has granted orphan drug designation to Terguride for the treatment of pulmonary arterial hypertension (PAH). Terguride is currently being evaluated for PAH in a pivotal Phase II trial in Europe.

"The FDA's grant of orphan drug designation to Terguride for PAH encourages and strengthens our development program by offering regulatory, clinical development and commercial benefits," said Dr Rudolf Reiter, CEO of Ergonex Pharma. "We believe that Terguride can provide a significant therapeutic benefit in PAH by inhibiting excess serotonin signalling."

The U.S. Orphan Drug Act is intended to assist and encourage companies to develop safe and effective therapies for the treatment of rare diseases, which affect 200.000 persons or less in the United States. Under the Orphan Drug Act, upon marketing authorization, the FDA does not accept or approve other applications to market the same medicinal product for the same indication for a seven-year period. In addition to potential market exclusivity, orphan drug designation provides protocol assistance, advice on the conduct of clinical trials, tax credits for clinical research expenses, grant funding for research of rare disease treatments and waiver of the Prescription Drug User Fee Act filing fee.

About Terguride

Terguride has strong anti-serotoninergic activity by acting as a potent antagonist on 5-HT2B and 5-HT2A receptors: It has anti-proliferative and anti-fibrotic activity and drives reverse remodelling processes. Serotonin is a signal molecule in the body with many functions. In the blood vessel walls of the lung it stimulates proliferation of smooth muscle cells and narrowing of the blood vessels, which leads to PAH. Excessive proliferative effects of serotonin on the heart contribute directly to progression towards heart failure.

Terguride is cli
'/>"/>

SOURCE Ergonex Pharma GmbH
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ... of injectable drug delivery systems, today announced the launch ... The new site includes additional products, videos, features, blogs ... regular basis. Mr. Alan Shortall , ... leader for injectable drug delivery systems, we have created ...
(Date:6/18/2013)... 18, 2013 MPR is excited to unveil ... edition. It,s all part of an ongoing effort to freshen ... practitioners for over 28 years. (Photo: ... evolution MPR has expanded upon its foundation as ... to include an increasing array of clinical and practice management ...
(Date:6/18/2013)... June 18, 2013 New-generation electronic designs ... portable and lightweight. Simultaneously, circuitry is increasing the ... speed to which it performs at. Connecting cables ... and military equipment, such as cameras or detectors, ... and nano-circular connectors include custom cable designs for ...
Breaking Medicine Technology:Unilife Launches New Corporate Website 2MPR Sports a Bold New Look 2Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2
(Date:6/18/2013)... New York (PRWEB) June 19, 2013 ... comprehensive understanding and unprecedented access to the drug delivery ... leading healthcare companies. , The report provides a ... enter drug delivery partnering deals. The majority of deals ... a right or an option right to license the ...
(Date:6/18/2013)... June 18, 2013 Senior drug regulatory officials ... June 25 to discuss—for the first time in the U.S.—the ... drugs through the regulatory process in a timely manner. Representatives ... will share respective best practices and processes in drug review ... panel at the DIA 2013 49th Annual Meeting ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Biomet ... continue to move forward in a multidistrict litigation in ... LLP reports. According to court records, the litigation’s ... at which time the Court also convened a motions ... issues pertinent to the Biomet hip replacement litigation. ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Internationally ... his new website, thebestbreast.com, showcasing his unique approach ... with information about his surgical method and highlights ... Outlined on his website, Dr. Tebbetts compares his ... traditional methods, Dr. Tebbetts’ method does not necessitate ...
(Date:6/18/2013)... at Case Western Reserve University,s College of Arts ... made available avatarsvirtual patientsto train speech-language pathologists. ... to evaluate speech-language disorders to practice using an ... because a diagnosis doesn,t have to be made ... studying to become speech-language pathologists have previously relied ...
Breaking Medicine News(10 mins):Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 2Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 4Health News:Renowned Regulatory Representatives From Mainland China and Taiwan to Discuss Need for Collaboration at DIA Meeting 2Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 2Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 3Health News:Internationally Acclaimed Breast Augmentation Expert Announces the Launch of His New Website 2Health News:SimuCase avatars advance speech-language pathology training 2
... the International Journal of Cancer it was found that drinking ... risk of developing bile stones. ,Billiary tract cancers ... other hand are seen in women and are linked to ... had undergone treatment for billiary tract cancer live over five ...
... jaundice at Pahihari village near here has caused a scare ... ,The local Primary Health Centre (PHC) here today constituted ... vulnerable to the diseases, they said., ,At least one ... suffering from either malaria or jaundice, the officials said., ...
... foods to the U.S., China, and Japan using vacuum ... ,Local food manufacturer, Terry Tan and Singapore Polytechnic are ... available worldwide. ,Extending shelf life to one ... Terry Tan’s plans a reality. According to Samuel Aw, ...
... flesh and a few dollars more. This might seem sickening, ... falling sick and dying and if that happens, //they hit ... trading or betting on someone’s life is unabashedly termed 'Life ... undoubtedly hope after a hopeless situation and a saving grace ...
... cough syrups, is actually no better than placebo or ... seems to deal effectively with suppressing cough, but actually ... a study on 24 patients with chronic obstructive pulmonary ... in the Journal of Allergy and Clinical Immunology. The ...
... took part in a workshop to discuss the various ... and the West have different approaches to cosmetic surgery. ... like leprosy and burns than on aesthetic surgery," Anil ... Indo-Italian workshop, Aesthetica 2006. ,He added: "But of ...
Cached Medicine News:
1-Day Acuvue brand contact lenses offer the healthiest, most convenient way to wear contact lenses. There's no lens care or messy solutions required, just wear them one day and throw them away....
... Magellan Mapper connects via a ... or desktop computer featuring Windows ... state of the art corneal ... bright ring projection and easy ...
... Oculus Easygraph is a corneal topographer ... you need for refractive surgery, contact ... contact lens fitting in a small ... package. All you need to supply ...
Available in 10 beautiful opaque colors....
Medicine Products: